#begin document (nw/wsj/12/wsj_1246); part 000
nw/wsj/12/wsj_1246   0    0            Two     CD     (TOP(S(NP*            -    -   -   -    (CARDINAL)  (ARG0*         *             *            *           *    (16
nw/wsj/12/wsj_1246   0    1       Japanese     JJ              *            -    -   -   -        (NORP)       *         *             *            *           *      -
nw/wsj/12/wsj_1246   0    2     scientists    NNS              *)           -    -   -   -            *        *)        *             *            *           *     16)
nw/wsj/12/wsj_1246   0    3           said    VBD           (VP*           say  01   1   -            *      (V*)        *             *            *           *     (5)
nw/wsj/12/wsj_1246   0    4           they    PRP    (SBAR(S(NP*)           -    -   -   -            *   (ARG1*    (ARG0*)            *            *           *    (16)
nw/wsj/12/wsj_1246   0    5     discovered    VBD           (VP*      discover  01   1   -            *        *       (V*)            *            *           *     (6)
nw/wsj/12/wsj_1246   0    6             an     DT        (NP(NP*            -    -   -   -            *        *    (ARG1*             *       (ARG0*      (ARG0*     (0
nw/wsj/12/wsj_1246   0    7       antibody     NN              *)           -    -   -   -            *        *         *             *            *)          *)     -
nw/wsj/12/wsj_1246   0    8           that     IN    (SBAR(WHNP*)           -    -   -   -            *        *         *             *     (R-ARG0*)   (R-ARG0*)     -
nw/wsj/12/wsj_1246   0    9              ,      ,              *            -    -   -   -            *        *         *             *            *           *      -
nw/wsj/12/wsj_1246   0   10             in     IN         (S(PP*            -    -   -   -            *        *         *             *   (ARGM-LOC*           *      -
nw/wsj/12/wsj_1246   0   11     laboratory     NN           (NP*            -    -   -   -            *        *         *    (ARGM-LOC*)           *           *    (15
nw/wsj/12/wsj_1246   0   12           test     NN          (NML*            -    -   -   -            *        *         *        (ARG2*            *           *      -
nw/wsj/12/wsj_1246   0   13             -    HYPH              *            -    -   -   -            *        *         *             *            *           *      -
nw/wsj/12/wsj_1246   0   14           tube     NN              *)           -    -   -   -            *        *         *             *)           *           *      -
nw/wsj/12/wsj_1246   0   15    experiments    NNS             *))   experiment  01   1   -            *        *         *           (V*)           *)          *     15)
nw/wsj/12/wsj_1246   0   16              ,      ,              *            -    -   -   -            *        *         *             *            *           *      -
nw/wsj/12/wsj_1246   0   17          kills    VBZ           (VP*          kill  01   1   -            *        *         *             *          (V*)          *      -
nw/wsj/12/wsj_1246   0   18           AIDS    NNP      (NP(ADJP*            -    -   -   -            *        *         *             *       (ARG1*           *     (9
nw/wsj/12/wsj_1246   0   19             -    HYPH              *            -    -   -   -            *        *         *             *            *           *      -
nw/wsj/12/wsj_1246   0   20       infected    VBN              *)           -    -   -   -            *        *         *             *            *           *      9)
nw/wsj/12/wsj_1246   0   21          cells    NNS              *)         cell   -   1   -            *        *         *             *            *)          *      -
nw/wsj/12/wsj_1246   0   22          while     IN         (SBAR*            -    -   -   -            *        *         *             *   (ARGM-TMP*           *      -
nw/wsj/12/wsj_1246   0   23     preserving    VBG         (S(VP*      preserve  01   2   -            *        *         *             *            *         (V*)     -
nw/wsj/12/wsj_1246   0   24        healthy     JJ           (NP*            -    -   -   -            *        *         *             *            *      (ARG1*      -
nw/wsj/12/wsj_1246   0   25          cells    NNS   *))))))))))))         cell   -   1   -            *        *)        *)            *            *)          *)     0)
nw/wsj/12/wsj_1246   0   26              .      .             *))           -    -   -   -            *        *         *             *            *           *      -

nw/wsj/12/wsj_1246   0    0             If    IN  (TOP(S(SBAR*            -    -   -   -   *             *         *    (ARGM-ADV*             *        *     -
nw/wsj/12/wsj_1246   0    1        further    JJ        (S(NP*            -    -   -   -   *    (ARGM-EXT*)   (ARG1*             *             *        *   (11
nw/wsj/12/wsj_1246   0    2    experiments   NNS             *)   experiment  01   1   -   *           (V*)        *)            *             *        *    11)
nw/wsj/12/wsj_1246   0    3            are   VBP          (VP*            be  01   1   -   *             *       (V*)            *             *        *     -
nw/wsj/12/wsj_1246   0    4     successful    JJ     (ADJP*))))           -    -   -   -   *             *    (ARG2*)            *)            *        *     -
nw/wsj/12/wsj_1246   0    5              ,     ,             *            -    -   -   -   *             *         *             *             *        *     -
nw/wsj/12/wsj_1246   0    6            the    DT          (NP*            -    -   -   -   *             *         *        (ARG0*             *        *   (11
nw/wsj/12/wsj_1246   0    7           work    NN             *)           -    -   -   -   *             *         *             *)            *        *    11)
nw/wsj/12/wsj_1246   0    8          would    MD          (VP*            -    -   -   -   *             *         *    (ARGM-MOD*)            *        *     -
nw/wsj/12/wsj_1246   0    9      represent    VB          (VP*     represent  01   1   -   *             *         *           (V*)            *        *     -
nw/wsj/12/wsj_1246   0   10              a    DT       (NP(NP*            -    -   -   -   *             *         *        (ARG1*             *        *     -
nw/wsj/12/wsj_1246   0   11          major    JJ             *            -    -   -   -   *             *         *             *    (ARGM-EXT*)       *     -
nw/wsj/12/wsj_1246   0   12        advance    NN             *)      advance  01   2   -   *             *         *             *           (V*)       *     -
nw/wsj/12/wsj_1246   0   13             in    IN          (PP*            -    -   -   -   *             *         *             *        (ARG1*        *     -
nw/wsj/12/wsj_1246   0   14       research    NN       (NP(NP*)     research   -   1   -   *             *         *             *             *        *     -
nw/wsj/12/wsj_1246   0   15             on    IN          (PP*            -    -   -   -   *             *         *             *             *        *     -
nw/wsj/12/wsj_1246   0   16       acquired   VBN      (NP(NML*       acquire  01   -   -   *             *         *             *             *      (V*)   (9
nw/wsj/12/wsj_1246   0   17         immune    JJ             *            -    -   -   -   *             *         *             *             *   (ARG1*     -
nw/wsj/12/wsj_1246   0   18     deficiency    NN             *)           -    -   -   -   *             *         *             *             *        *     -
nw/wsj/12/wsj_1246   0   19       syndrome    NN       *)))))))           -    -   -   -   *             *         *             *)            *)       *)    9)
nw/wsj/12/wsj_1246   0   20              .     .            *))           -    -   -   -   *             *         *             *             *        *     -

nw/wsj/12/wsj_1246   0    0          The    DT  (TOP(S(NP(NP*           -    -   -   -           *   (ARG0*   (ARG0*   (ARG0*        *        (ARG3*    (7
nw/wsj/12/wsj_1246   0    1         drug    NN              *           -    -   -   -           *        *        *        *        *             *     -
nw/wsj/12/wsj_1246   0    2          AZT   NNP              *)          -    -   -   -    (PRODUCT)       *        *        *        *             *     -
nw/wsj/12/wsj_1246   0    3            ,     ,              *           -    -   -   -           *        *        *        *        *             *     -
nw/wsj/12/wsj_1246   0    4          the    DT        (NP(NP*           -    -   -   -           *        *        *        *        *             *     -
nw/wsj/12/wsj_1246   0    5         only    JJ              *           -    -   -   -           *        *        *        *        *             *     -
nw/wsj/12/wsj_1246   0    6    treatment    NN              *)   treatment   -   1   -           *        *        *        *        *             *     -
nw/wsj/12/wsj_1246   0    7    currently    RB     (RRC(ADVP*)          -    -   -   -           *        *        *        *        *             *     -
nw/wsj/12/wsj_1246   0    8           on    IN           (PP*           -    -   -   -           *        *        *        *        *             *     -
nw/wsj/12/wsj_1246   0    9          the    DT           (NP*           -    -   -   -           *        *        *        *        *             *     -
nw/wsj/12/wsj_1246   0   10       market    NN           *))))      market   -   1   -           *        *        *        *        *             *     -
nw/wsj/12/wsj_1246   0   11            ,     ,              *)          -    -   -   -           *        *)       *)       *)       *             *)    7)
nw/wsj/12/wsj_1246   0   12       claims   VBZ           (VP*        claim  01   1   -           *      (V*)       *        *        *             *     -
nw/wsj/12/wsj_1246   0   13         only    RB       (S(ADVP*)          -    -   -   -           *   (ARG1*        *        *        *             *     -
nw/wsj/12/wsj_1246   0   14           to    TO        (VP(VP*           -    -   -   -           *        *        *        *        *             *     -
nw/wsj/12/wsj_1246   0   15         help    VB           (VP*         help  01   1   -           *        *      (V*)       *        *             *     -
nw/wsj/12/wsj_1246   0   16         stop    VB         (S(VP*         stop  01   2   -           *        *   (ARG1*      (V*)       *             *     -
nw/wsj/12/wsj_1246   0   17          the    DT        (NP(NP*           -    -   -   -           *        *        *   (ARG1*        *             *     -
nw/wsj/12/wsj_1246   0   18       spread    NN              *)      spread  02   1   -           *        *        *        *      (V*)            *     -
nw/wsj/12/wsj_1246   0   19           of    IN           (PP*           -    -   -   -           *        *        *        *   (ARG1*             *     -
nw/wsj/12/wsj_1246   0   20         AIDS   NNP     (NP*)))))))          -    -   -   -           *        *        *)       *)       *)            *    (9)
nw/wsj/12/wsj_1246   0   21            ,     ,              *           -    -   -   -           *        *        *        *        *             *     -
nw/wsj/12/wsj_1246   0   22          not    RB              *           -    -   -   -           *        *        *        *        *    (ARGM-NEG*)    -
nw/wsj/12/wsj_1246   0   23           to    TO           (VP*           -    -   -   -           *        *        *        *        *             *     -
nw/wsj/12/wsj_1246   0   24         cure    VB           (VP*         cure  01   1   -           *        *        *        *        *           (V*)    -
nw/wsj/12/wsj_1246   0   25           it   PRP      (NP*))))))          -    -   -   -           *        *)       *        *        *        (ARG2*)   (9)
nw/wsj/12/wsj_1246   0   26            .     .             *))          -    -   -   -           *        *        *        *        *             *     -

nw/wsj/12/wsj_1246   0    0             But    CC       (TOP(S*              -    -   -   -        *            *             *            *      -
nw/wsj/12/wsj_1246   0    1         several    JJ    (NP(NP(NP*              -    -   -   -        *            *             *       (ARG0*      -
nw/wsj/12/wsj_1246   0    2        analysts   NNS             *)        analyst   -   1   -        *            *             *            *      -
nw/wsj/12/wsj_1246   0    3             and    CC             *              -    -   -   -        *            *             *            *      -
nw/wsj/12/wsj_1246   0    4        Japanese    JJ          (NP*              -    -   -   -    (NORP)           *             *            *      -
nw/wsj/12/wsj_1246   0    5      scientists   NNS            *))             -    -   -   -        *            *             *            *      -
nw/wsj/12/wsj_1246   0    6        familiar    JJ        (ADJP*              -    -   -   -        *            *             *            *      -
nw/wsj/12/wsj_1246   0    7            with    IN          (PP*              -    -   -   -        *            *             *            *      -
nw/wsj/12/wsj_1246   0    8             the    DT       (NP(NP*              -    -   -   -        *            *        (ARG1*            *      -
nw/wsj/12/wsj_1246   0    9           study    NN             *)          study  01   3   -        *          (V*)            *)           *      -
nw/wsj/12/wsj_1246   0   10               ,     ,             *              -    -   -   -        *            *             *            *      -
nw/wsj/12/wsj_1246   0   11           which   WDT   (SBAR(WHNP*)             -    -   -   -        *   (ARGM-ADJ*      (R-ARG1*)           *      -
nw/wsj/12/wsj_1246   0   12             was   VBD        (S(VP*              -    -   -   -        *            *             *            *      -
nw/wsj/12/wsj_1246   0   13       announced   VBN          (VP*        announce  01   1   -        *            *           (V*)           *      -
nw/wsj/12/wsj_1246   0   14              at    IN          (PP*              -    -   -   -        *            *    (ARGM-LOC*            *      -
nw/wsj/12/wsj_1246   0   15               a    DT       (NP(NP*              -    -   -   -        *            *             *            *      -
nw/wsj/12/wsj_1246   0   16      conference    NN             *)     conference   -   1   -        *            *             *            *      -
nw/wsj/12/wsj_1246   0   17              in    IN          (PP*              -    -   -   -        *            *             *            *      -
nw/wsj/12/wsj_1246   0   18          Nagoya   NNP       (NP*))))             -    -   -   -     (GPE)           *             *)           *      -
nw/wsj/12/wsj_1246   0   19       yesterday    NN      (NP*)))))      yesterday   -   1   -    (DATE)           *)   (ARGM-TMP*)           *    (13)
nw/wsj/12/wsj_1246   0   20               ,     ,          *))))             -    -   -   -        *            *             *            *)     -
nw/wsj/12/wsj_1246   0   21       expressed   VBD          (VP*         express  01   1   -        *            *             *          (V*)     -
nw/wsj/12/wsj_1246   0   22      skepticism    NN          (NP*)             -    -   -   -        *            *             *       (ARG1*)     -
nw/wsj/12/wsj_1246   0   23            over    IN          (PP*              -    -   -   -        *            *             *   (ARGM-ADV*      -
nw/wsj/12/wsj_1246   0   24             the    DT       (NP(NP*              -    -   -   -        *            *             *            *      -
nw/wsj/12/wsj_1246   0   25    significance    NN             *)   significance   -   1   -        *            *             *            *      -
nw/wsj/12/wsj_1246   0   26              of    IN          (PP*              -    -   -   -        *            *             *            *      -
nw/wsj/12/wsj_1246   0   27             the    DT          (NP*              -    -   -   -        *            *             *            *     (4
nw/wsj/12/wsj_1246   0   28         results   NNS         *)))))         result   -   3   -        *            *             *            *)     4)
nw/wsj/12/wsj_1246   0   29               .     .            *))             -    -   -   -        *            *             *            *      -

nw/wsj/12/wsj_1246   0    0             And    CC             (TOP(S*             -    -   -   -   *    (ARGM-DIS*)            *             *             *      -
nw/wsj/12/wsj_1246   0    1             the    DT             (NP(NP*             -    -   -   -   *        (ARG0*             *             *             *    (16
nw/wsj/12/wsj_1246   0    2     researchers   NNS                   *)            -    -   -   -   *             *             *             *             *      -
nw/wsj/12/wsj_1246   0    3      themselves   PRP               (NP*))            -    -   -   -   *             *)            *             *             *     16)
nw/wsj/12/wsj_1246   0    4    acknowledged   VBD                (VP*    acknowledge  01   1   -   *           (V*)            *             *             *      -
nw/wsj/12/wsj_1246   0    5            they   PRP         (SBAR(S(NP*)            -    -   -   -   *        (ARG1*        (ARG0*)            *             *    (16)
nw/wsj/12/wsj_1246   0    6           still    RB              (ADVP*)            -    -   -   -   *             *    (ARGM-ADV*)            *             *      -
nw/wsj/12/wsj_1246   0    7            must    MD                (VP*             -    -   -   -   *             *    (ARGM-MOD*)            *             *      -
nw/wsj/12/wsj_1246   0    8              do    VB                (VP*             do  02   1   -   *             *           (V*)            *             *      -
nw/wsj/12/wsj_1246   0    9            much    RB           (NP(ADJP*             -    -   -   -   *             *        (ARG1*             *             *      -
nw/wsj/12/wsj_1246   0   10            more   JJR                   *)            -    -   -   -   *             *             *             *             *      -
nw/wsj/12/wsj_1246   0   11            work    NN                   *)            -    -   -   -   *             *             *)            *             *      -
nw/wsj/12/wsj_1246   0   12          before    IN              (SBAR*             -    -   -   -   *             *    (ARGM-TMP*             *             *      -
nw/wsj/12/wsj_1246   0   13            they   PRP              (S(NP*)            -    -   -   -   *             *             *        (ARG0*)            *    (16)
nw/wsj/12/wsj_1246   0   14             can    MD                (VP*             -    -   -   -   *             *             *    (ARGM-MOD*)            *      -
nw/wsj/12/wsj_1246   0   15             say    VB                (VP*            say  01   6   -   *             *             *           (V*)            *      -
nw/wsj/12/wsj_1246   0   16         whether    IN              (SBAR*             -    -   -   -   *             *             *        (ARG1*             *      -
nw/wsj/12/wsj_1246   0   17             the    DT              (S(NP*             -    -   -   -   *             *             *             *        (ARG3*      -
nw/wsj/12/wsj_1246   0   18       treatment    NN                   *)     treatment   -   1   -   *             *             *             *             *)     -
nw/wsj/12/wsj_1246   0   19           would    MD                (VP*             -    -   -   -   *             *             *             *    (ARGM-MOD*)     -
nw/wsj/12/wsj_1246   0   20        actually    RB              (ADVP*)            -    -   -   -   *             *             *             *    (ARGM-ADV*)     -
nw/wsj/12/wsj_1246   0   21            cure    VB                (VP*           cure  01   1   -   *             *             *             *           (V*)     -
nw/wsj/12/wsj_1246   0   22          humans   NNS   (NP*))))))))))))))            -    -   -   -   *             *)            *)            *)       (ARG1*)     -
nw/wsj/12/wsj_1246   0   23               .     .                  *))            -    -   -   -   *             *             *             *             *      -

nw/wsj/12/wsj_1246   0    0              Shin    NNP    (TOP(S(NP(NP*           -    -   -   -   (PERSON*   (ARG0*         *            *        *        *           *    (1
nw/wsj/12/wsj_1246   0    1          Yonehara    NNP                *)          -    -   -   -          *)       *         *            *        *        *           *     -
nw/wsj/12/wsj_1246   0    2                 ,      ,                *           -    -   -   -          *        *         *            *        *        *           *     -
nw/wsj/12/wsj_1246   0    3                 a     DT          (NP(NP*           -    -   -   -          *        *         *            *        *        *           *     -
nw/wsj/12/wsj_1246   0    4          research     NN                *           -    -   -   -          *        *         *            *        *        *           *     -
nw/wsj/12/wsj_1246   0    5         scientist     NN                *)          -    -   -   -          *        *         *            *        *        *           *     -
nw/wsj/12/wsj_1246   0    6                at     IN             (PP*           -    -   -   -          *        *         *            *        *        *           *     -
nw/wsj/12/wsj_1246   0    7               the     DT          (NP(NP*           -    -   -   -      (ORG*        *         *            *        *        *           *     -
nw/wsj/12/wsj_1246   0    8             Tokyo    NNP                *           -    -   -   -          *        *         *            *        *        *           *     -
nw/wsj/12/wsj_1246   0    9      Metropolitan    NNP                *           -    -   -   -          *        *         *            *        *        *           *     -
nw/wsj/12/wsj_1246   0   10         Institute    NNP                *)          -    -   -   -          *        *         *            *        *        *           *     -
nw/wsj/12/wsj_1246   0   11                of     IN             (PP*           -    -   -   -          *        *         *            *        *        *           *     -
nw/wsj/12/wsj_1246   0   12           Medical    NNP             (NP*           -    -   -   -          *        *         *            *        *        *           *     -
nw/wsj/12/wsj_1246   0   13           Science    NNP            *)))))          -    -   -   -          *)       *         *            *        *        *           *     -
nw/wsj/12/wsj_1246   0   14                 ,      ,                *)          -    -   -   -          *        *)        *            *        *        *           *     1)
nw/wsj/12/wsj_1246   0   15              said    VBD             (VP*          say  01   1   -          *      (V*)        *            *        *        *           *     -
nw/wsj/12/wsj_1246   0   16               the     DT   (SBAR(S(NP(NP*           -    -   -   -          *   (ARG1*    (ARG1*       (ARG0*   (ARG0*        *           *    (0
nw/wsj/12/wsj_1246   0   17          antibody     NN                *)          -    -   -   -          *        *         *)           *        *        *           *     -
nw/wsj/12/wsj_1246   0   18                he    PRP      (SBAR(S(NP*)          -    -   -   -          *        *    (ARG0*)           *        *        *           *    (1)
nw/wsj/12/wsj_1246   0   19        discovered    VBD          (VP*))))    discover  01   1   -          *        *       (V*)           *)       *)       *           *     0)
nw/wsj/12/wsj_1246   0   20             works    VBZ             (VP*         work  01   2   -          *        *         *          (V*)       *        *           *     -
nw/wsj/12/wsj_1246   0   21                by     IN             (PP*           -    -   -   -          *        *         *   (ARGM-MNR*        *        *           *     -
nw/wsj/12/wsj_1246   0   22       recognizing    VBG           (S(VP*    recognize  01   1   -          *        *         *            *      (V*)       *           *     -
nw/wsj/12/wsj_1246   0   23                an     DT       (NP(NP(NP*           -    -   -   -          *        *         *            *   (ARG1*   (ARG1*      (ARG1*     -
nw/wsj/12/wsj_1246   0   24           antigen     NN                *)          -    -   -   -          *        *         *            *        *        *)          *     -
nw/wsj/12/wsj_1246   0   25            called    VBN             (VP*         call  01   5   -          *        *         *            *        *      (V*)          *     -
nw/wsj/12/wsj_1246   0   26                 a     DT           (S(NP*           -    -   -   -          *        *         *            *        *   (ARG2*           *     -
nw/wsj/12/wsj_1246   0   27               Fas    NNP                *           -    -   -   -          *        *         *            *        *        *           *     -
nw/wsj/12/wsj_1246   0   28                -    HYPH                *           -    -   -   -          *        *         *            *        *        *           *     -
nw/wsj/12/wsj_1246   0   29           antigen    NNP             *))))          -    -   -   -          *        *         *            *        *        *)          *)    -
nw/wsj/12/wsj_1246   0   30                 ,      ,                *           -    -   -   -          *        *         *            *        *        *           *     -
nw/wsj/12/wsj_1246   0   31             which    WDT      (SBAR(WHNP*)          -    -   -   -          *        *         *            *        *        *    (R-ARG1*)    -
nw/wsj/12/wsj_1246   0   32                is    VBZ           (S(VP*           be  01   1   -          *        *         *            *        *        *         (V*)    -
nw/wsj/12/wsj_1246   0   33    characteristic     JJ           (ADJP*           -    -   -   -          *        *         *            *        *        *      (ARG2*     -
nw/wsj/12/wsj_1246   0   34                of     IN             (PP*           -    -   -   -          *        *         *            *        *        *           *     -
nw/wsj/12/wsj_1246   0   35                an     DT             (NP*           -    -   -   -          *        *         *            *        *        *           *    (8
nw/wsj/12/wsj_1246   0   36          infected     JJ                *           -    -   -   -          *        *         *            *        *        *           *     -
nw/wsj/12/wsj_1246   0   37              cell     NN   *))))))))))))))        cell   -   1   -          *        *)        *            *)       *)       *           *)    8)
nw/wsj/12/wsj_1246   0   38                 .      .               *))          -    -   -   -          *        *         *            *        *        *           *     -

nw/wsj/12/wsj_1246   0   0         The    DT  (TOP(S(NP*      -    -   -   -   *        (ARG0*   (0
nw/wsj/12/wsj_1246   0   1    antibody    NN           *)     -    -   -   -   *             *)   0)
nw/wsj/12/wsj_1246   0   2        then    RB      (ADVP*)     -    -   -   -   *    (ARGM-TMP*)   -
nw/wsj/12/wsj_1246   0   3       kills   VBZ        (VP*    kill  01   1   -   *           (V*)   -
nw/wsj/12/wsj_1246   0   4         the    DT        (NP*      -    -   -   -   *        (ARG1*   (8
nw/wsj/12/wsj_1246   0   5        cell    NN          *))   cell   -   1   -   *             *)   8)
nw/wsj/12/wsj_1246   0   6           .     .          *))     -    -   -   -   *             *    -

nw/wsj/12/wsj_1246   0    0            Dr.    NNP  (TOP(S(NP(NP*            -    -   -   -           *   (ARG0*         *        *            *     (1|(16
nw/wsj/12/wsj_1246   0    1       Yonehara    NNP              *)           -    -   -   -     (PERSON)       *         *        *            *          1)
nw/wsj/12/wsj_1246   0    2            and     CC              *            -    -   -   -           *        *         *        *            *          -
nw/wsj/12/wsj_1246   0    3            his   PRP$        (NP(NP*            -    -   -   -           *        *         *        *            *     (12|(1)
nw/wsj/12/wsj_1246   0    4        partner     NN              *)      partner   -   2   -           *        *         *        *            *          -
nw/wsj/12/wsj_1246   0    5              ,      ,              *            -    -   -   -           *        *         *        *            *          -
nw/wsj/12/wsj_1246   0    6       Nobuyuki    NNP        (NP(NP*            -    -   -   -    (PERSON*        *         *        *            *          -
nw/wsj/12/wsj_1246   0    7      Kobayashi    NNP              *)           -    -   -   -           *)       *         *        *            *          -
nw/wsj/12/wsj_1246   0    8             of     IN           (PP*            -    -   -   -           *        *         *        *            *          -
nw/wsj/12/wsj_1246   0    9      Yamaguchi    NNP           (NP*            -    -   -   -       (ORG*        *         *        *            *          -
nw/wsj/12/wsj_1246   0   10     University    NNP            *)))           -    -   -   -           *)       *         *        *            *          -
nw/wsj/12/wsj_1246   0   11              ,      ,             *))           -    -   -   -           *        *)        *        *            *     16)|12)
nw/wsj/12/wsj_1246   0   12           said    VBD           (VP*           say  01   1   -           *      (V*)        *        *            *          -
nw/wsj/12/wsj_1246   0   13          their   PRP$    (SBAR(S(NP*            -    -   -   -           *   (ARG1*    (ARG0*)  (ARG0*            *    (15|(16)
nw/wsj/12/wsj_1246   0   14    experiments    NNS              *)   experiment  01   1   -           *        *       (V*)       *)           *         15)
nw/wsj/12/wsj_1246   0   15         showed    VBD           (VP*          show  01   1   -           *        *         *      (V*)           *          -
nw/wsj/12/wsj_1246   0   16           that     IN         (SBAR*            -    -   -   -           *        *         *   (ARG1*            *          -
nw/wsj/12/wsj_1246   0   17            the     DT         (S(NP*            -    -   -   -           *        *         *        *       (ARG0*         (0
nw/wsj/12/wsj_1246   0   18       antibody     NN              *)           -    -   -   -           *        *         *        *            *)         0)
nw/wsj/12/wsj_1246   0   19          wiped    VBD           (VP*          wipe  02   2   -           *        *         *        *          (V*)         -
nw/wsj/12/wsj_1246   0   20            out     RP          (PRT*)           -    -   -   -           *        *         *        *            *          -
nw/wsj/12/wsj_1246   0   21             an     DT        (NP(NP*            -    -   -   -           *        *         *        *       (ARG1*          -
nw/wsj/12/wsj_1246   0   22        average     NN              *)      average   -   1   -           *        *         *        *            *          -
nw/wsj/12/wsj_1246   0   23             of     IN           (PP*            -    -   -   -           *        *         *        *            *          -
nw/wsj/12/wsj_1246   0   24            60      CD        (NP(NP*            -    -   -   -   (PERCENT*        *         *        *            *          -
nw/wsj/12/wsj_1246   0   25              %     NN              *)           -    -   -   -           *)       *         *        *            *          -
nw/wsj/12/wsj_1246   0   26             of     IN           (PP*            -    -   -   -           *        *         *        *            *          -
nw/wsj/12/wsj_1246   0   27           AIDS    NNP      (NP(ADJP*            -    -   -   -           *        *         *        *            *         (9
nw/wsj/12/wsj_1246   0   28             -    HYPH              *            -    -   -   -           *        *         *        *            *          -
nw/wsj/12/wsj_1246   0   29       infected    VBN              *)           -    -   -   -           *        *         *        *            *          9)
nw/wsj/12/wsj_1246   0   30          cells    NNS          *)))))         cell   -   1   -           *        *         *        *            *)         -
nw/wsj/12/wsj_1246   0   31         within     IN           (PP*            -    -   -   -           *        *         *        *   (ARGM-TMP*          -
nw/wsj/12/wsj_1246   0   32          three     CD           (NP*            -    -   -   -      (DATE*        *         *        *            *          -
nw/wsj/12/wsj_1246   0   33           days    NNS      *)))))))))          day   -   2   -           *)       *)        *        *)           *)         -
nw/wsj/12/wsj_1246   0   34              .      .             *))           -    -   -   -           *        *         *        *            *          -

nw/wsj/12/wsj_1246   0    0             In    IN  (TOP(S(S(PP*            -    -   -   -   *      *   (ARGM-LOC*   (ARG1*     -
nw/wsj/12/wsj_1246   0    1           some    DT       (NP(NP*)           -    -   -   -   *      *            *        *     -
nw/wsj/12/wsj_1246   0    2             of    IN          (PP*            -    -   -   -   *      *            *        *     -
nw/wsj/12/wsj_1246   0    3            the    DT          (NP*            -    -   -   -   *      *            *        *   (15
nw/wsj/12/wsj_1246   0    4    experiments   NNS          *))))   experiment  01   1   -   *    (V*)           *)       *    15)
nw/wsj/12/wsj_1246   0    5              ,     ,             *            -    -   -   -   *      *            *        *     -
nw/wsj/12/wsj_1246   0    6             it   PRP          (NP*)           -    -   -   -   *      *       (ARG0*)       *    (0)
nw/wsj/12/wsj_1246   0    7         killed   VBD          (VP*          kill  01   1   -   *      *          (V*)       *     -
nw/wsj/12/wsj_1246   0    8         almost    RB       (NP(QP*            -    -   -   -   *      *       (ARG1*        *     -
nw/wsj/12/wsj_1246   0    9            all   PDT             *)           -    -   -   -   *      *            *        *     -
nw/wsj/12/wsj_1246   0   10            the    DT             *            -    -   -   -   *      *            *        *     -
nw/wsj/12/wsj_1246   0   11       infected    JJ             *            -    -   -   -   *      *            *        *     -
nw/wsj/12/wsj_1246   0   12          cells   NNS           *)))         cell   -   1   -   *      *            *)       *)    -
nw/wsj/12/wsj_1246   0   13              ,     ,             *            -    -   -   -   *      *            *        *     -
nw/wsj/12/wsj_1246   0   14            the    DT          (NP*            -    -   -   -   *      *            *   (ARG0*   (16
nw/wsj/12/wsj_1246   0   15    researchers   NNS             *)           -    -   -   -   *      *            *        *)   16)
nw/wsj/12/wsj_1246   0   16           said   VBD          (VP*)          say  01   1   -   *      *            *      (V*)    -
nw/wsj/12/wsj_1246   0   17              .     .            *))           -    -   -   -   *      *            *        *     -

nw/wsj/12/wsj_1246   0    0    Meanwhile    RB   (TOP(S(ADVP*)     -    -   -   -           *    (ARGM-DIS*)  -
nw/wsj/12/wsj_1246   0    1            ,     ,              *      -    -   -   -           *             *   -
nw/wsj/12/wsj_1246   0    2        fewer   JJR     (NP(NP(QP*      -    -   -   -   (PERCENT*        (ARG1*   -
nw/wsj/12/wsj_1246   0    3         than    IN              *      -    -   -   -           *             *   -
nw/wsj/12/wsj_1246   0    4          10     CD              *)     -    -   -   -           *             *   -
nw/wsj/12/wsj_1246   0    5            %    NN              *)     -    -   -   -           *)            *   -
nw/wsj/12/wsj_1246   0    6           of    IN           (PP*      -    -   -   -           *             *   -
nw/wsj/12/wsj_1246   0    7          the    DT           (NP*      -    -   -   -           *             *   -
nw/wsj/12/wsj_1246   0    8      healthy    JJ              *      -    -   -   -           *             *   -
nw/wsj/12/wsj_1246   0    9        cells   NNS            *)))   cell   -   1   -           *             *)  -
nw/wsj/12/wsj_1246   0   10         were   VBD           (VP*      -    -   -   -           *             *   -
nw/wsj/12/wsj_1246   0   11       killed   VBN          (VP*))   kill  01   1   -           *           (V*)  -
nw/wsj/12/wsj_1246   0   12            .     .             *))     -    -   -   -           *             *   -

nw/wsj/12/wsj_1246   0    0           The    DT    (TOP(S(NP*            -    -   -   -            *   (ARG0*             *    (16
nw/wsj/12/wsj_1246   0    1           two    CD             *)           -    -   -   -    (CARDINAL)       *)            *     16)
nw/wsj/12/wsj_1246   0    2          said   VBD          (VP*           say  01   1   -            *      (V*)            *      -
nw/wsj/12/wsj_1246   0    3          they   PRP   (SBAR(S(NP*)           -    -   -   -            *   (ARG1*        (ARG0*)   (16)
nw/wsj/12/wsj_1246   0    4          must    MD          (VP*            -    -   -   -            *        *    (ARGM-MOD*)     -
nw/wsj/12/wsj_1246   0    5         still    RB        (ADVP*)           -    -   -   -            *        *    (ARGM-ADV*)     -
nw/wsj/12/wsj_1246   0    6            do    VB       (VP(VP*            do  02   1   -            *        *           (V*)     -
nw/wsj/12/wsj_1246   0    7          more   JJR          (NP*            -    -   -   -            *        *        (ARG1*      -
nw/wsj/12/wsj_1246   0    8    laboratory    NN             *            -    -   -   -            *        *             *      -
nw/wsj/12/wsj_1246   0    9         tests   NNS            *))         test   -   1   -            *        *             *)     -
nw/wsj/12/wsj_1246   0   10             ,     ,             *            -    -   -   -            *        *             *      -
nw/wsj/12/wsj_1246   0   11          then    RB             *            -    -   -   -            *        *             *      -
nw/wsj/12/wsj_1246   0   12    experiment    NN          (VP*    experiment   -   1   -            *        *             *      -
nw/wsj/12/wsj_1246   0   13            on    IN          (PP*            -    -   -   -            *        *             *      -
nw/wsj/12/wsj_1246   0   14       animals   NNS   (NP*))))))))           -    -   -   -            *        *)            *      -
nw/wsj/12/wsj_1246   0   15             .     .            *))           -    -   -   -            *        *             *      -

nw/wsj/12/wsj_1246   0    0        They   PRP    (TOP(S(NP*)        -    -   -   -        *    (ARG0*)        *            *    (16)
nw/wsj/12/wsj_1246   0    1        said   VBD          (VP*        say  01   1   -        *       (V*)        *            *      -
nw/wsj/12/wsj_1246   0    2        they   PRP   (SBAR(S(NP*)        -    -   -   -        *    (ARG1*    (ARG0*)      (ARG0*)   (16)
nw/wsj/12/wsj_1246   0    3       hoped   VBD          (VP*       hope  01   1   -        *         *       (V*)           *      -
nw/wsj/12/wsj_1246   0    4          to    TO        (S(VP*         -    -   -   -        *         *    (ARG1*            *      -
nw/wsj/12/wsj_1246   0    5     conduct    VB          (VP*    conduct  01   2   -        *         *         *          (V*)     -
nw/wsj/12/wsj_1246   0    6       tests   NNS          (NP*)      test   -   1   -        *         *         *       (ARG1*)     -
nw/wsj/12/wsj_1246   0    7          on    IN          (PP*         -    -   -   -        *         *         *   (ARGM-LOC*      -
nw/wsj/12/wsj_1246   0    8       human    JJ       (NP(NP*         -    -   -   -        *         *         *            *      -
nw/wsj/12/wsj_1246   0    9    patients   NNS             *)        -    -   -   -        *         *         *            *      -
nw/wsj/12/wsj_1246   0   10          in    IN          (PP*         -    -   -   -        *         *         *            *      -
nw/wsj/12/wsj_1246   0   11         the    DT          (NP*         -    -   -   -        *         *         *            *      -
nw/wsj/12/wsj_1246   0   12        U.S.   NNP          *))))        -    -   -   -     (GPE)        *         *            *)     -
nw/wsj/12/wsj_1246   0   13          by    IN          (PP*         -    -   -   -        *         *         *   (ARGM-TMP*      -
nw/wsj/12/wsj_1246   0   14        late    RB     (NP(ADVP*)        -    -   -   -   (DATE*         *         *            *      -
nw/wsj/12/wsj_1246   0   15        next    JJ             *         -    -   -   -        *         *         *            *      -
nw/wsj/12/wsj_1246   0   16        year    NN     *)))))))))        -    -   -   -        *)        *)        *)           *)     -
nw/wsj/12/wsj_1246   0   17           .     .            *))        -    -   -   -        *         *         *            *      -

nw/wsj/12/wsj_1246   0    0              Japan   NNP   (TOP(S(S(NP*)        -    -   -   -    (GPE)       (ARG0*)      (ARG0*)        *     (3)
nw/wsj/12/wsj_1246   0    1               does   VBZ           (VP*         -    -   -   -       *             *            *         *      -
nw/wsj/12/wsj_1246   0    2                n't    RB              *         -    -   -   -       *    (ARGM-NEG*)           *         *      -
nw/wsj/12/wsj_1246   0    3               have    VB           (VP*       have  03   5   -       *           (V*)           *         *      -
nw/wsj/12/wsj_1246   0    4             enough    JJ           (NP*         -    -   -   -       *        (ARG1*            *         *      -
nw/wsj/12/wsj_1246   0    5               AIDS   NNP              *         -    -   -   -       *             *            *         *     (9)
nw/wsj/12/wsj_1246   0    6           patients   NNS              *         -    -   -   -       *             *            *         *      -
nw/wsj/12/wsj_1246   0    7                 to    TO         (S(VP*         -    -   -   -       *             *            *         *      -
nw/wsj/12/wsj_1246   0    8                 do    VB           (VP*         do  02   1   -       *             *          (V*)        *      -
nw/wsj/12/wsj_1246   0    9        significant    JJ           (NP*         -    -   -   -       *             *       (ARG1*         *      -
nw/wsj/12/wsj_1246   0   10    experimentation    NN              *)        -    -   -   -       *             *            *)        *      -
nw/wsj/12/wsj_1246   0   11                 in    IN           (PP*         -    -   -   -       *             *   (ARGM-LOC*         *      -
nw/wsj/12/wsj_1246   0   12               that    DT           (NP*         -    -   -   -       *             *            *         *     (3
nw/wsj/12/wsj_1246   0   13            country    NN      *)))))))))   country   -   3   -       *             *)           *)        *      3)
nw/wsj/12/wsj_1246   0   14                  ,     ,              *         -    -   -   -       *             *            *         *      -
nw/wsj/12/wsj_1246   0   15               they   PRP           (NP*)        -    -   -   -       *             *            *    (ARG0*)   (16)
nw/wsj/12/wsj_1246   0   16               said   VBD           (VP*)       say  01   1   -       *             *            *       (V*)     -
nw/wsj/12/wsj_1246   0   17                  .     .             *))        -    -   -   -       *             *            *         *      -

nw/wsj/12/wsj_1246   0    0               The    DT  (TOP(S(NP*              -    -   -   -        *      *       (ARG0*             *        (ARG0*     (5
nw/wsj/12/wsj_1246   0    1      announcement    NN           *)   announcement  01   1   -        *    (V*)           *)            *             *)     5)
nw/wsj/12/wsj_1246   0    2               got   VBD     (VP(VP*             get  01   1   -        *      *          (V*)            *             *      -
nw/wsj/12/wsj_1246   0    3              wide    JJ        (NP*              -    -   -   -        *      *       (ARG1*    (ARGM-EXT*)            *      -
nw/wsj/12/wsj_1246   0    4          exposure    NN           *)       exposure  01   7   -        *      *            *)          (V*)            *      -
nw/wsj/12/wsj_1246   0    5                in    IN        (PP*              -    -   -   -        *      *   (ARGM-LOC*             *             *      -
nw/wsj/12/wsj_1246   0    6               the    DT        (NP*              -    -   -   -        *      *            *             *             *      -
nw/wsj/12/wsj_1246   0    7          Japanese    JJ           *              -    -   -   -    (NORP)     *            *             *             *      -
nw/wsj/12/wsj_1246   0    8             media   NNS         *)))         medium   -   8   -        *      *            *)            *             *      -
nw/wsj/12/wsj_1246   0    9                 ,     ,           *              -    -   -   -        *      *            *             *             *      -
nw/wsj/12/wsj_1246   0   10               and    CC           *              -    -   -   -        *      *            *             *             *      -
nw/wsj/12/wsj_1246   0   11              even    RB      (ADVP*)             -    -   -   -        *      *            *             *    (ARGM-ADV*)     -
nw/wsj/12/wsj_1246   0   12             moved   VBD        (VP*            move  01   1   -        *      *            *             *           (V*)     -
nw/wsj/12/wsj_1246   0   13              some    DT        (NP*              -    -   -   -        *      *            *             *        (ARG1*      -
nw/wsj/12/wsj_1246   0   14    pharmaceutical    NN           *              -    -   -   -        *      *            *             *             *      -
nw/wsj/12/wsj_1246   0   15            stocks   NNS           *)          stock   -   1   -        *      *            *             *             *)     -
nw/wsj/12/wsj_1246   0   16         yesterday    NN      (NP*)))      yesterday   -   1   -    (DATE)     *            *             *    (ARGM-TMP*)   (13)
nw/wsj/12/wsj_1246   0   17                 .     .          *))             -    -   -   -        *      *            *             *             *      -

nw/wsj/12/wsj_1246   0    0            But     CC      (TOP(S*            -    -   -   -          *    (ARGM-DIS*)            *             *      -
nw/wsj/12/wsj_1246   0    1        Takashi    NNP      (NP(NP*            -    -   -   -   (PERSON*        (ARG0*             *             *    (14
nw/wsj/12/wsj_1246   0    2       Kitamura    NNP            *)           -    -   -   -          *)            *             *             *      -
nw/wsj/12/wsj_1246   0    3              ,      ,            *            -    -   -   -          *             *             *             *      -
nw/wsj/12/wsj_1246   0    4       director     NN   (NP(NP(NP*)     director   -   1   -          *             *             *             *      -
nw/wsj/12/wsj_1246   0    5             of     IN         (PP*            -    -   -   -          *             *             *             *      -
nw/wsj/12/wsj_1246   0    6            the     DT      (NP(NP*            -    -   -   -          *             *             *             *      -
nw/wsj/12/wsj_1246   0    7        biology     NN            *            -    -   -   -          *             *             *             *      -
nw/wsj/12/wsj_1246   0    8     department     NN            *)   department   -   1   -          *             *             *             *      -
nw/wsj/12/wsj_1246   0    9             at     IN         (PP*            -    -   -   -          *             *             *             *      -
nw/wsj/12/wsj_1246   0   10          Japan    NNP   (NP(NP(NP*            -    -   -   -       (GPE)            *             *             *     (3
nw/wsj/12/wsj_1246   0   11             's    POS            *)           -    -   -   -          *             *             *             *      3)
nw/wsj/12/wsj_1246   0   12       National    NNP            *            -    -   -   -      (ORG*             *             *             *      -
nw/wsj/12/wsj_1246   0   13      Institute    NNP            *)           -    -   -   -          *             *             *             *      -
nw/wsj/12/wsj_1246   0   14             of     IN         (PP*            -    -   -   -          *             *             *             *      -
nw/wsj/12/wsj_1246   0   15         Health    NNP   (NP*)))))))           -    -   -   -          *)            *             *             *      -
nw/wsj/12/wsj_1246   0   16            and     CC            *            -    -   -   -          *             *             *             *      -
nw/wsj/12/wsj_1246   0   17      secretary     NN      (NP(NP*)    secretary   -   1   -          *             *             *             *      -
nw/wsj/12/wsj_1246   0   18             of     IN         (PP*            -    -   -   -          *             *             *             *      -
nw/wsj/12/wsj_1246   0   19            the     DT      (NP(NP*            -    -   -   -          *             *             *             *     (3
nw/wsj/12/wsj_1246   0   20     government     NN            *    government   -   1   -          *             *             *             *      -
nw/wsj/12/wsj_1246   0   21             's    POS            *)           -    -   -   -          *             *             *             *      3)
nw/wsj/12/wsj_1246   0   22           AIDS    NNP        (NML*            -    -   -   -          *             *             *             *     (9
nw/wsj/12/wsj_1246   0   23             -    HYPH            *            -    -   -   -          *             *             *             *      -
nw/wsj/12/wsj_1246   0   24       research     NN            *)           -    -   -   -          *             *             *             *      9)
nw/wsj/12/wsj_1246   0   25         center     NN         *))))       center   -   2   -          *             *             *             *      -
nw/wsj/12/wsj_1246   0   26              ,      ,            *)           -    -   -   -          *             *)            *             *     14)
nw/wsj/12/wsj_1246   0   27           said    VBD         (VP*           say  01   1   -          *           (V*)            *             *      -
nw/wsj/12/wsj_1246   0   28              ,      ,            *            -    -   -   -          *             *             *             *      -
nw/wsj/12/wsj_1246   0   29             ``     ``            *            -    -   -   -          *             *             *             *      -
nw/wsj/12/wsj_1246   0   30              I    PRP       (S(NP*)           -    -   -   -          *        (ARG1*        (ARG1*)            *    (14)
nw/wsj/12/wsj_1246   0   31             'm    VBP         (VP*            be  01   1   -          *             *           (V*)            *      -
nw/wsj/12/wsj_1246   0   32            not     RB            *            -    -   -   -          *             *    (ARGM-NEG*)            *      -
nw/wsj/12/wsj_1246   0   33             so     RB       (ADJP*            -    -   -   -          *             *        (ARG2*             *      -
nw/wsj/12/wsj_1246   0   34     optimistic     JJ            *            -    -   -   -          *             *             *             *      -
nw/wsj/12/wsj_1246   0   35             of     IN         (PP*            -    -   -   -          *             *             *             *      -
nw/wsj/12/wsj_1246   0   36            its   PRP$      (NP(NP*            -    -   -   -          *             *             *        (ARG1*)    (0)
nw/wsj/12/wsj_1246   0   37         future     JJ            *            -    -   -   -          *             *             *    (ARGM-TMP*)     -
nw/wsj/12/wsj_1246   0   38            use     NN            *)          use  01   2   -          *             *             *           (V*)     -
nw/wsj/12/wsj_1246   0   39             in     IN         (PP*            -    -   -   -          *             *             *        (ARG2*      -
nw/wsj/12/wsj_1246   0   40    therapeutic     JJ         (NP*            -    -   -   -          *             *             *             *      -
nw/wsj/12/wsj_1246   0   41        methods    NNS     *))))))))           -    -   -   -          *             *)            *)            *)     -
nw/wsj/12/wsj_1246   0   42              .      .            *            -    -   -   -          *             *             *             *      -
nw/wsj/12/wsj_1246   0   43             ''     ''           *))           -    -   -   -          *             *             *             *      -

nw/wsj/12/wsj_1246   0    0          He   PRP    (TOP(S(NP*)         -    -   -   -   *    (ARG0*)            *             *        *    (14)
nw/wsj/12/wsj_1246   0    1        said   VBD          (VP*         say  01   1   -   *       (V*)            *             *        *      -
nw/wsj/12/wsj_1246   0    2        some    DT   (SBAR(S(NP*          -    -   -   -   *    (ARG1*        (ARG0*        (ARG1*        *      -
nw/wsj/12/wsj_1246   0    3    infected    JJ             *          -    -   -   -   *         *             *             *        *      -
nw/wsj/12/wsj_1246   0    4       cells   NNS             *)       cell   -   1   -   *         *             *)            *)       *      -
nw/wsj/12/wsj_1246   0    5         may    MD       (VP(VP*          -    -   -   -   *         *    (ARGM-MOD*)            *        *      -
nw/wsj/12/wsj_1246   0    6         not    RB             *          -    -   -   -   *         *    (ARGM-NEG*)            *        *      -
nw/wsj/12/wsj_1246   0    7        have    VB          (VP*        have  03   2   -   *         *           (V*)            *        *      -
nw/wsj/12/wsj_1246   0    8         the    DT          (NP*          -    -   -   -   *         *        (ARG1*             *        *      -
nw/wsj/12/wsj_1246   0    9    relevant    JJ             *          -    -   -   -   *         *             *             *        *      -
nw/wsj/12/wsj_1246   0   10     antigen    NN           *)))         -    -   -   -   *         *             *)            *        *      -
nw/wsj/12/wsj_1246   0   11         and    CC             *          -    -   -   -   *         *             *             *        *      -
nw/wsj/12/wsj_1246   0   12          so    RB        (ADVP*)         -    -   -   -   *         *             *    (ARGM-DIS*)       *      -
nw/wsj/12/wsj_1246   0   13       would    MD          (VP*          -    -   -   -   *         *             *    (ARGM-MOD*)       *      -
nw/wsj/12/wsj_1246   0   14         n't    RB             *          -    -   -   -   *         *             *    (ARGM-NEG*)       *      -
nw/wsj/12/wsj_1246   0   15          be    VB          (VP*          -    -   -   -   *         *             *             *        *      -
nw/wsj/12/wsj_1246   0   16      killed   VBN          (VP*        kill  01   1   -   *         *             *           (V*)       *      -
nw/wsj/12/wsj_1246   0   17        even    RB     (PP(ADVP*)         -    -   -   -   *         *             *    (ARGM-TMP*        *      -
nw/wsj/12/wsj_1246   0   18       after    IN             *          -    -   -   -   *         *             *             *        *      -
nw/wsj/12/wsj_1246   0   19    exposure    NN       (NP(NP*)   exposure  01   2   -   *         *             *             *      (V*)     -
nw/wsj/12/wsj_1246   0   20          to    IN          (PP*          -    -   -   -   *         *             *             *   (ARG2*      -
nw/wsj/12/wsj_1246   0   21         the    DT          (NP*          -    -   -   -   *         *             *             *        *     (0
nw/wsj/12/wsj_1246   0   22    antibody    NN   *)))))))))))         -    -   -   -   *         *)            *             *)       *)     0)
nw/wsj/12/wsj_1246   0   23           .     .            *))         -    -   -   -   *         *             *             *        *      -

nw/wsj/12/wsj_1246   0    0               ``    ``  (TOP(SINV*        -    -   -   -          *          *        *        *        *    -
nw/wsj/12/wsj_1246   0    1              The    DT      (S(NP*        -    -   -   -          *     (ARG1*   (ARG1*   (ARG1*        *   (4
nw/wsj/12/wsj_1246   0    2          results   NNS           *)   result   -   3   -          *          *)       *)       *        *    4)
nw/wsj/12/wsj_1246   0    3             seem   VBP        (VP*      seem  01   1   -          *        (V*)       *        *        *    -
nw/wsj/12/wsj_1246   0    4               to    TO      (S(VP*        -    -   -   -          *   (C-ARG1*        *        *        *    -
nw/wsj/12/wsj_1246   0    5               be    VB        (VP*        be  01   1   -          *          *      (V*)       *        *    -
nw/wsj/12/wsj_1246   0    6             very    RB      (ADJP*        -    -   -   -          *          *   (ARG2*        *        *    -
nw/wsj/12/wsj_1246   0    7        premature    JJ      *))))))       -    -   -   -          *          *)       *)       *)       *    -
nw/wsj/12/wsj_1246   0    8                ,     ,           *        -    -   -   -          *          *        *        *        *    -
nw/wsj/12/wsj_1246   0    9               ''    ''           *        -    -   -   -          *          *        *        *        *    -
nw/wsj/12/wsj_1246   0   10             said   VBD        (VP*)      say  01   1   -          *          *        *      (V*)       *    -
nw/wsj/12/wsj_1246   0   11          Mitsuru   NNP     (NP(NP*        -    -   -   -   (PERSON*          *        *   (ARG0*        *    -
nw/wsj/12/wsj_1246   0   12           Miyata   NNP           *)       -    -   -   -          *)         *        *        *        *    -
nw/wsj/12/wsj_1246   0   13                ,     ,           *        -    -   -   -          *          *        *        *        *    -
nw/wsj/12/wsj_1246   0   14           editor    NN     (NP(NP*)       -    -   -   -          *          *        *        *        *    -
nw/wsj/12/wsj_1246   0   15               of    IN        (PP*        -    -   -   -          *          *        *        *        *    -
nw/wsj/12/wsj_1246   0   16           Nikkei   NNP     (NP(NP*        -    -   -   -      (ORG*          *        *        *        *    -
nw/wsj/12/wsj_1246   0   17    Biotechnology   NNP           *)       -    -   -   -          *)         *        *        *        *    -
nw/wsj/12/wsj_1246   0   18                ,     ,           *        -    -   -   -          *          *        *        *        *    -
nw/wsj/12/wsj_1246   0   19                a    DT        (NP*        -    -   -   -          *          *        *        *        *    -
nw/wsj/12/wsj_1246   0   20          leading   VBG           *      lead  01   2   -          *          *        *        *      (V*)   -
nw/wsj/12/wsj_1246   0   21         Japanese    JJ           *        -    -   -   -      (NORP)         *        *        *   (ARG0*    -
nw/wsj/12/wsj_1246   0   22         industry    NN           *        -    -   -   -          *          *        *        *        *    -
nw/wsj/12/wsj_1246   0   23       newsletter    NN       *)))))       -    -   -   -          *          *        *        *)       *)   -
nw/wsj/12/wsj_1246   0   24                .     .          *))       -    -   -   -          *          *        *        *        *    -

nw/wsj/12/wsj_1246   0    0            Dr.   NNP   (TOP(S(NP*         -    -   -   -          *   (ARG0*         *             *    (12
nw/wsj/12/wsj_1246   0    1      Kobayashi   NNP            *)        -    -   -   -    (PERSON)       *)        *             *     12)
nw/wsj/12/wsj_1246   0    2      responded   VBD         (VP*    respond  01   2   -          *      (V*)        *             *      -
nw/wsj/12/wsj_1246   0    3           that    IN       (SBAR*         -    -   -   -          *   (ARG2*         *             *      -
nw/wsj/12/wsj_1246   0    4             he   PRP       (S(NP*)        -    -   -   -          *        *    (ARG0*)            *    (12)
nw/wsj/12/wsj_1246   0    5        thought   VBD         (VP*      think  01   1   -          *        *       (V*)            *      -
nw/wsj/12/wsj_1246   0    6            the    DT  (SBAR(S(NP*         -    -   -   -          *        *    (ARG1*        (ARG0*     (0
nw/wsj/12/wsj_1246   0    7       antibody    NN            *)        -    -   -   -          *        *         *             *)     0)
nw/wsj/12/wsj_1246   0    8          could    MD         (VP*         -    -   -   -          *        *         *    (ARGM-MOD*)     -
nw/wsj/12/wsj_1246   0    9    potentially    RB       (ADVP*)        -    -   -   -          *        *         *    (ARGM-ADV*)     -
nw/wsj/12/wsj_1246   0   10           kill    VB         (VP*       kill  01   1   -          *        *         *           (V*)     -
nw/wsj/12/wsj_1246   0   11            all    DT         (NP*         -    -   -   -          *        *         *        (ARG1*      -
nw/wsj/12/wsj_1246   0   12       infected    JJ            *         -    -   -   -          *        *         *             *      -
nw/wsj/12/wsj_1246   0   13          cells   NNS    *)))))))))      cell   -   1   -          *        *)        *)            *)     -
nw/wsj/12/wsj_1246   0   14              .     .           *))        -    -   -   -          *        *         *             *      -

nw/wsj/12/wsj_1246   0    0              But    CC       (TOP(S*        -    -   -   -          *    (ARGM-DIS*)            *          -
nw/wsj/12/wsj_1246   0    1               he   PRP       (NP(NP*)       -    -   -   -          *        (ARG0*             *    (16|(12)
nw/wsj/12/wsj_1246   0    2              and    CC             *        -    -   -   -          *             *             *          -
nw/wsj/12/wsj_1246   0    3              Dr.   NNP          (NP*        -    -   -   -          *             *             *         (1
nw/wsj/12/wsj_1246   0    4         Yonehara   NNP            *))       -    -   -   -    (PERSON)            *)            *      16)|1)
nw/wsj/12/wsj_1246   0    5             said   VBD          (VP*       say  01   1   -          *           (V*)            *          -
nw/wsj/12/wsj_1246   0    6            there    EX   (SBAR(S(NP*)       -    -   -   -          *        (ARG1*             *          -
nw/wsj/12/wsj_1246   0    7             were   VBD          (VP*        be  02   3   -          *             *           (V*)         -
nw/wsj/12/wsj_1246   0    8            still    RB        (ADVP*)       -    -   -   -          *             *    (ARGM-TMP*)         -
nw/wsj/12/wsj_1246   0    9          several    JJ       (NP(NP*        -    -   -   -          *             *        (ARG1*          -
nw/wsj/12/wsj_1246   0   10    uncertainties   NNS             *)       -    -   -   -          *             *             *          -
nw/wsj/12/wsj_1246   0   11                ,     ,             *        -    -   -   -          *             *             *          -
nw/wsj/12/wsj_1246   0   12     particularly    RB    (RRC(ADVP*)       -    -   -   -          *             *             *          -
nw/wsj/12/wsj_1246   0   13        regarding   VBG          (PP*    regard   -   3   -          *             *             *          -
nw/wsj/12/wsj_1246   0   14         possible    JJ          (NP*        -    -   -   -          *             *             *          -
nw/wsj/12/wsj_1246   0   15             side    NN             *      side   -   9   -          *             *             *          -
nw/wsj/12/wsj_1246   0   16          effects   NNS      *))))))))   effect   -   1   -          *             *)            *)         -
nw/wsj/12/wsj_1246   0   17                .     .            *))       -    -   -   -          *             *             *          -

nw/wsj/12/wsj_1246   0    0              ``     ``  (TOP(SINV*      -    -   -   -          *             *             *        *         -
nw/wsj/12/wsj_1246   0    1             Our   PRP$    (S(S(NP*      -    -   -   -          *        (ARG0*             *   (ARG1*    (0|(16)
nw/wsj/12/wsj_1246   0    2        antibody     NN           *)     -    -   -   -          *             *)            *        *         0)
nw/wsj/12/wsj_1246   0    3    specifically     RB      (ADVP*)     -    -   -   -          *    (ARGM-ADV*)            *        *         -
nw/wsj/12/wsj_1246   0    4          killed    VBD        (VP*    kill  01   1   -          *           (V*)            *        *         -
nw/wsj/12/wsj_1246   0    5        infected     JJ        (NP*      -    -   -   -          *        (ARG1*             *        *         -
nw/wsj/12/wsj_1246   0    6           cells    NNS           *)   cell   -   1   -          *             *)            *        *         -
nw/wsj/12/wsj_1246   0    7              at     IN        (PP*      -    -   -   -          *    (ARGM-MNR*             *        *         -
nw/wsj/12/wsj_1246   0    8               a     DT        (NP*      -    -   -   -          *             *             *        *         -
nw/wsj/12/wsj_1246   0    9            very     RB      (ADJP*      -    -   -   -          *             *             *        *         -
nw/wsj/12/wsj_1246   0   10             low     JJ           *)     -    -   -   -          *             *             *        *         -
nw/wsj/12/wsj_1246   0   11            dose     NN        *))))     -    -   -   -          *             *)            *        *         -
nw/wsj/12/wsj_1246   0   12               ,      ,           *      -    -   -   -          *             *             *        *         -
nw/wsj/12/wsj_1246   0   13             but     CC           *      -    -   -   -          *             *             *        *         -
nw/wsj/12/wsj_1246   0   14              it    PRP      (S(NP*)     -    -   -   -          *             *        (ARG0*)       *        (0)
nw/wsj/12/wsj_1246   0   15             can     MD        (VP*      -    -   -   -          *             *    (ARGM-MOD*)       *         -
nw/wsj/12/wsj_1246   0   16            also     RB      (ADVP*)     -    -   -   -          *             *    (ARGM-DIS*)       *         -
nw/wsj/12/wsj_1246   0   17            kill     VB        (VP*    kill  01   1   -          *             *           (V*)       *         -
nw/wsj/12/wsj_1246   0   18           other     JJ        (NP*      -    -   -   -          *             *        (ARG1*        *         -
nw/wsj/12/wsj_1246   0   19           cells    NNS       *)))))   cell   -   1   -          *             *             *)       *)        -
nw/wsj/12/wsj_1246   0   20               ,      ,           *      -    -   -   -          *             *             *        *         -
nw/wsj/12/wsj_1246   0   21              ''     ''           *      -    -   -   -          *             *             *        *         -
nw/wsj/12/wsj_1246   0   22            said    VBD        (VP*)    say  01   1   -          *             *             *      (V*)        -
nw/wsj/12/wsj_1246   0   23             Dr.    NNP        (NP*      -    -   -   -          *             *             *   (ARG0*        (1
nw/wsj/12/wsj_1246   0   24        Yonehara    NNP           *)     -    -   -   -    (PERSON)            *             *        *)        1)
nw/wsj/12/wsj_1246   0   25               .      .          *))     -    -   -   -          *             *             *        *         -

nw/wsj/12/wsj_1246   0    0          ``     ``  (TOP(S*        -    -   -   -   *             *         -
nw/wsj/12/wsj_1246   0    1          We    PRP     (NP*)       -    -   -   -   *        (ARG0*)      (16)
nw/wsj/12/wsj_1246   0    2          do    VBP     (VP*        -    -   -   -   *             *         -
nw/wsj/12/wsj_1246   0    3         n't     RB        *        -    -   -   -   *    (ARGM-NEG*)        -
nw/wsj/12/wsj_1246   0    4        know     VB     (VP*      know  01   1   -   *           (V*)        -
nw/wsj/12/wsj_1246   0    5         the     DT  (NP(NP*        -    -   -   -   *        (ARG1*         -
nw/wsj/12/wsj_1246   0    6      effect     NN        *)   effect   -   1   -   *             *         -
nw/wsj/12/wsj_1246   0    7          of     IN     (PP*        -    -   -   -   *             *         -
nw/wsj/12/wsj_1246   0    8         our   PRP$     (NP*        -    -   -   -   *             *    (0|(16)
nw/wsj/12/wsj_1246   0    9    antibody     NN       *))       -    -   -   -   *             *         0)
nw/wsj/12/wsj_1246   0   10          on     IN     (PP*        -    -   -   -   *             *         -
nw/wsj/12/wsj_1246   0   11         the     DT     (NP*        -    -   -   -   *             *         -
nw/wsj/12/wsj_1246   0   12       human     JJ        *        -    -   -   -   *             *         -
nw/wsj/12/wsj_1246   0   13        body     NN    *)))))     body   -   2   -   *             *)        -
nw/wsj/12/wsj_1246   0   14           .      .        *        -    -   -   -   *             *         -
nw/wsj/12/wsj_1246   0   15          ''     ''       *))       -    -   -   -   *             *         -

nw/wsj/12/wsj_1246   0    0           AIDS   NNP   (TOP(S(S(NP*)           -    -    -   -            *             *        *         *            *        *        *             *    (9)
nw/wsj/12/wsj_1246   0    1             is   VBZ           (VP*            -    -    -   -            *             *        *         *            *        *        *             *     -
nw/wsj/12/wsj_1246   0    2            n't    RB              *            -    -    -   -            *    (ARGM-NEG*)       *         *            *        *        *             *     -
nw/wsj/12/wsj_1246   0    3     considered   VBN           (VP*      consider  01    1   -            *           (V*)       *         *            *        *        *             *     -
nw/wsj/12/wsj_1246   0    4              a    DT      (S(NP(NP*            -    -    -   -            *        (ARG1*        *         *            *        *        *             *     -
nw/wsj/12/wsj_1246   0    5     widespread    JJ              *            -    -    -   -            *             *        *         *            *        *        *             *     -
nw/wsj/12/wsj_1246   0    6        problem    NN              *)      problem   -    1   -            *             *        *         *            *        *        *             *     -
nw/wsj/12/wsj_1246   0    7             in    IN           (PP*            -    -    -   -            *             *        *         *            *        *        *             *     -
nw/wsj/12/wsj_1246   0    8          Japan   NNP     (NP*)))))))           -    -    -   -         (GPE)            *)       *         *            *        *        *             *    (3)
nw/wsj/12/wsj_1246   0    9            --      :              *            -    -    -   -            *             *        *         *            *        *        *             *     -
nw/wsj/12/wsj_1246   0   10            the    DT         (S(NP*            -    -    -   -            *             *   (ARG0*         *            *        *        *             *    (3
nw/wsj/12/wsj_1246   0   11     government    NN              *)   government   -    1   -            *             *        *)        *            *        *        *             *     3)
nw/wsj/12/wsj_1246   0   12        reports   VBZ           (VP*        report  01    1   -            *             *      (V*)        *            *        *        *             *     -
nw/wsj/12/wsj_1246   0   13          about    IN     (NP(NP(QP*            -    -    -   -   (CARDINAL*             *   (ARG1*         *            *        *        *             *     -
nw/wsj/12/wsj_1246   0   14         1,000     CD              *)           -    -    -   -            *)            *        *         *            *        *        *             *     -
nw/wsj/12/wsj_1246   0   15          known   VBN              *          know  01    -   -            *             *        *       (V*)           *        *        *             *     -
nw/wsj/12/wsj_1246   0   16       carriers   NNS              *)      carrier   -   10   -            *             *        *    (ARG1*)           *        *        *             *     -
nw/wsj/12/wsj_1246   0   17             of    IN           (PP*            -    -    -   -            *             *        *         *            *        *        *             *     -
nw/wsj/12/wsj_1246   0   18            the    DT           (NP*            -    -    -   -            *             *        *         *            *        *        *             *    (9
nw/wsj/12/wsj_1246   0   19          virus    NN          *)))))           -    -    -   -            *             *        *)        *            *        *        *             *     9)
nw/wsj/12/wsj_1246   0   20            --      :              *            -    -    -   -            *             *        *         *            *        *        *             *     -
nw/wsj/12/wsj_1246   0   21            but    CC              *            -    -    -   -            *             *        *         *            *        *        *             *     -
nw/wsj/12/wsj_1246   0   22           many    JJ         (S(NP*            -    -    -   -            *             *        *         *       (ARG0*   (ARG0*   (ARG0*             *     -
nw/wsj/12/wsj_1246   0   23      companies   NNS              *)      company   -    1   -            *             *        *         *            *)       *)       *)            *     -
nw/wsj/12/wsj_1246   0   24           have   VBP           (VP*            -    -    -   -            *             *        *         *            *        *        *             *     -
nw/wsj/12/wsj_1246   0   25         poured   VBN           (VP*          pour  01    3   -            *             *        *         *          (V*)       *        *             *     -
nw/wsj/12/wsj_1246   0   26    substantial    JJ           (NP*            -    -    -   -            *             *        *         *       (ARG1*        *        *             *     -
nw/wsj/12/wsj_1246   0   27      resources   NNS              *)     resource   -    1   -            *             *        *         *            *)       *        *             *     -
nw/wsj/12/wsj_1246   0   28           into    IN           (PP*            -    -    -   -            *             *        *         *       (ARG3*        *        *             *     -
nw/wsj/12/wsj_1246   0   29       research    NN          (NP*))     research   -    1   -            *             *        *         *            *)       *        *             *     -
nw/wsj/12/wsj_1246   0   30             in    IN           (PP*            -    -    -   -            *             *        *         *   (ARGM-TMP*        *        *             *     -
nw/wsj/12/wsj_1246   0   31         recent    JJ           (NP*            -    -    -   -       (DATE*             *        *         *            *        *        *             *     -
nw/wsj/12/wsj_1246   0   32          years   NNS             *))           -    -    -   -            *)            *        *         *            *)       *        *             *     -
nw/wsj/12/wsj_1246   0   33              ,     ,              *            -    -    -   -            *             *        *         *            *        *        *             *     -
nw/wsj/12/wsj_1246   0   34         hoping   VBG         (S(VP*          hope  01    1   -            *             *        *         *   (ARGM-ADV*      (V*)       *             *     -
nw/wsj/12/wsj_1246   0   35             to    TO         (S(VP*            -    -    -   -            *             *        *         *            *   (ARG1*        *             *     -
nw/wsj/12/wsj_1246   0   36           cash    VB           (VP*          cash  03    2   -            *             *        *         *            *        *      (V*)            *     -
nw/wsj/12/wsj_1246   0   37             in    RP          (PRT*)           -    -    -   -            *             *        *         *            *        *        *             *     -
nw/wsj/12/wsj_1246   0   38             on    IN           (PP*            -    -    -   -            *             *        *         *            *        *   (ARG1*             *     -
nw/wsj/12/wsj_1246   0   39              a    DT           (NP*            -    -    -   -            *             *        *         *            *        *        *             *     -
nw/wsj/12/wsj_1246   0   40       possible    JJ              *            -    -    -   -            *             *        *         *            *        *        *    (ARGM-ADJ*)    -
nw/wsj/12/wsj_1246   0   41           cure    NN     *))))))))))         cure  01    1   -            *             *        *         *            *)       *)       *)          (V*)    -
nw/wsj/12/wsj_1246   0   42              .     .             *))           -    -    -   -            *             *        *         *            *        *        *             *     -

nw/wsj/12/wsj_1246   0    0            Dr.   NNP           (TOP(S(NP*         -    -   -   -            *             *             *   (14
nw/wsj/12/wsj_1246   0    1       Kitamura   NNP                    *)        -    -   -   -      (PERSON)            *             *    14)
nw/wsj/12/wsj_1246   0    2           said   VBD                 (VP*         -    -   -   -            *             *             *     -
nw/wsj/12/wsj_1246   0    3          about    IN  (SBAR(SBAR(S(NP(QP*         -    -   -   -   (CARDINAL*        (ARG1*             *     -
nw/wsj/12/wsj_1246   0    4            35     CD                    *)        -    -   -   -            *)            *             *     -
nw/wsj/12/wsj_1246   0    5       projects   NNS                    *)   project   -   1   -            *             *)            *     -
nw/wsj/12/wsj_1246   0    6            are   VBP                 (VP*         be  01   1   -            *           (V*)            *     -
nw/wsj/12/wsj_1246   0    7      currently    RB               (ADVP*)        -    -   -   -            *    (ARGM-TMP*)            *     -
nw/wsj/12/wsj_1246   0    8          under    IN                 (PP*         -    -   -   -            *        (ARG2*             *     -
nw/wsj/12/wsj_1246   0    9            way    NN                (NP*))       way   -   4   -            *             *)            *     -
nw/wsj/12/wsj_1246   0   10             in    IN                 (PP*         -    -   -   -            *    (ARGM-LOC*             *     -
nw/wsj/12/wsj_1246   0   11          Japan   NNP             (NP*)))))        -    -   -   -         (GPE)            *)            *    (3)
nw/wsj/12/wsj_1246   0   12              ,     ,                    *         -    -   -   -            *             *             *     -
nw/wsj/12/wsj_1246   0   13            and    CC                    *         -    -   -   -            *             *             *     -
nw/wsj/12/wsj_1246   0   14           that    IN               (SBAR*         -    -   -   -            *             *             *     -
nw/wsj/12/wsj_1246   0   15       Japanese    JJ            (S(NP(NP*         -    -   -   -        (NORP)            *             *     -
nw/wsj/12/wsj_1246   0   16    researchers   NNS                    *)        -    -   -   -            *             *             *     -
nw/wsj/12/wsj_1246   0   17             in    IN                 (PP*         -    -   -   -            *             *             *     -
nw/wsj/12/wsj_1246   0   18            the    DT                 (NP*         -    -   -   -       (DATE*             *             *     -
nw/wsj/12/wsj_1246   0   19           past    JJ                    *         -    -   -   -            *             *             *     -
nw/wsj/12/wsj_1246   0   20           year    NN                  *)))        -    -   -   -            *)            *             *     -
nw/wsj/12/wsj_1246   0   21           have   VBP                 (VP*         -    -   -   -            *             *             *     -
nw/wsj/12/wsj_1246   0   22           made   VBN                 (VP*         -    -   -   -            *             *             *     -
nw/wsj/12/wsj_1246   0   23      available    JJ             (S(ADJP*)        -    -   -   -            *             *             *     -
nw/wsj/12/wsj_1246   0   24          three    CD                 (NP*         -    -   -   -    (CARDINAL)            *             *     -
nw/wsj/12/wsj_1246   0   25       possible    JJ                    *         -    -   -   -            *             *    (ARGM-ADJ*)    -
nw/wsj/12/wsj_1246   0   26          cures   NNS                    *)      cure  01   1   -            *             *           (V*)    -
nw/wsj/12/wsj_1246   0   27             to    IN                 (PP*         -    -   -   -            *             *             *     -
nw/wsj/12/wsj_1246   0   28       American    JJ                 (NP*         -    -   -   -        (NORP)            *             *     -
nw/wsj/12/wsj_1246   0   29    researchers   NNS                   *))        -    -   -   -            *             *             *     -
nw/wsj/12/wsj_1246   0   30            for    IN                 (PP*         -    -   -   -            *             *             *     -
nw/wsj/12/wsj_1246   0   31       clinical    JJ                 (NP*         -    -   -   -            *             *             *     -
nw/wsj/12/wsj_1246   0   32          tests   NNS            *)))))))))      test   -   1   -            *             *             *     -
nw/wsj/12/wsj_1246   0   33              .     .                   *))        -    -   -   -            *             *             *     -

nw/wsj/12/wsj_1246   0    0            He   PRP         (TOP(S(NP*)        -    -   -   -            *    (ARG0*)            *             *    (14)
nw/wsj/12/wsj_1246   0    1          said   VBD               (VP*        say  01   1   -            *       (V*)            *             *      -
nw/wsj/12/wsj_1246   0    2          that    IN             (SBAR*         -    -   -   -            *    (ARG1*             *             *      -
nw/wsj/12/wsj_1246   0    3          when   WRB    (S(SBAR(WHADVP*)        -    -   -   -            *         *    (ARGM-TMP*)   (ARGM-TMP*      -
nw/wsj/12/wsj_1246   0    4    scientists   NNS          (S(NP(NP*)        -    -   -   -            *         *        (ARG0*             *      -
nw/wsj/12/wsj_1246   0    5          from    IN               (PP*         -    -   -   -            *         *             *             *      -
nw/wsj/12/wsj_1246   0    6           the    DT               (NP*         -    -   -   -            *         *             *             *      -
nw/wsj/12/wsj_1246   0    7           two    CD                  *         -    -   -   -    (CARDINAL)        *             *             *      -
nw/wsj/12/wsj_1246   0    8     countries   NNS                *)))   country   -   3   -            *         *             *)            *      -
nw/wsj/12/wsj_1246   0    9          meet   VBP               (VP*       meet  03   2   -            *         *           (V*)            *      -
nw/wsj/12/wsj_1246   0   10         again    RB             (ADVP*)        -    -   -   -            *         *    (ARGM-TMP*)            *      -
nw/wsj/12/wsj_1246   0   11            in    IN               (PP*         -    -   -   -            *         *    (ARGM-TMP*             *      -
nw/wsj/12/wsj_1246   0   12       January   NNP              (NP*))        -    -   -   -        (DATE)        *             *)            *      -
nw/wsj/12/wsj_1246   0   13            in    IN               (PP*         -    -   -   -            *         *    (ARGM-LOC*             *      -
nw/wsj/12/wsj_1246   0   14           New   NNP               (NP*         -    -   -   -        (GPE*         *             *             *      -
nw/wsj/12/wsj_1246   0   15       Orleans   NNP              *)))))        -    -   -   -            *)        *             *)            *)     -
nw/wsj/12/wsj_1246   0   16             ,     ,                  *         -    -   -   -            *         *             *             *      -
nw/wsj/12/wsj_1246   0   17           the    DT               (NP*         -    -   -   -            *         *             *        (ARG0*      -
nw/wsj/12/wsj_1246   0   18      Japanese   NNP                  *)        -    -   -   -        (NORP)        *             *             *)     -
nw/wsj/12/wsj_1246   0   19          will    MD               (VP*         -    -   -   -            *         *             *    (ARGM-MOD*)     -
nw/wsj/12/wsj_1246   0   20       present    VB               (VP*    present  01   3   -            *         *             *           (V*)     -
nw/wsj/12/wsj_1246   0   21            at    RB  (NP(ADJP(QP(ADVP*         -    -   -   -   (CARDINAL*         *             *        (ARG1*      -
nw/wsj/12/wsj_1246   0   22         least   RBS                  *)        -    -   -   -            *         *             *             *      -
nw/wsj/12/wsj_1246   0   23         three    CD                  *)        -    -   -   -            *)        *             *             *      -
nw/wsj/12/wsj_1246   0   24          more   JJR                  *)        -    -   -   -            *         *             *             *      -
nw/wsj/12/wsj_1246   0   25         drugs   NNS                  *)      drug   -   1   -            *         *             *             *)     -
nw/wsj/12/wsj_1246   0   26           for    IN               (PP*         -    -   -   -            *         *             *    (ARGM-PNC*      -
nw/wsj/12/wsj_1246   0   27         human    JJ               (NP*         -    -   -   -            *         *             *             *      -
nw/wsj/12/wsj_1246   0   28       testing    NN            *)))))))      test   -   4   -            *         *)            *             *)     -
nw/wsj/12/wsj_1246   0   29             .     .                 *))        -    -   -   -            *         *             *             *      -

nw/wsj/12/wsj_1246   0    0             AZT   NNP   (TOP(S(NP*)         -    -   -   -    (PRODUCT)   (ARG1*)       *        *    (7)
nw/wsj/12/wsj_1246   0    1              is   VBZ         (VP*          be  01   2   -           *       (V*)       *        *     -
nw/wsj/12/wsj_1246   0    2             the    DT   (NP(NP(NP*          -    -   -   -           *    (ARG2*   (ARG1*   (ARG3*     -
nw/wsj/12/wsj_1246   0    3           world    NN            *       world   -   1   -           *         *        *        *     -
nw/wsj/12/wsj_1246   0    4              's   POS            *)         -    -   -   -           *         *        *        *     -
nw/wsj/12/wsj_1246   0    5            only    JJ            *          -    -   -   -           *         *        *        *     -
nw/wsj/12/wsj_1246   0    6    prescription    NN            *          -    -   -   -           *         *        *        *     -
nw/wsj/12/wsj_1246   0    7        medicine    NN            *)   medicine   -   1   -           *         *        *)       *)    -
nw/wsj/12/wsj_1246   0    8        approved   VBN         (VP*     approve  01   1   -           *         *      (V*)       *     -
nw/wsj/12/wsj_1246   0    9             for    IN         (PP*          -    -   -   -           *         *   (ARG2*        *     -
nw/wsj/12/wsj_1246   0   10        treating   VBG       (S(VP*       treat  03   4   -           *         *        *      (V*)    -
nw/wsj/12/wsj_1246   0   11             the    DT         (NP*          -    -   -   -           *         *        *   (ARG2*    (9
nw/wsj/12/wsj_1246   0   12         disease    NN      *)))))))         -    -   -   -           *         *)       *)       *)    9)
nw/wsj/12/wsj_1246   0   13               .     .           *))         -    -   -   -           *         *        *        *     -

nw/wsj/12/wsj_1246   0    0          Wellcome   NNP  (TOP(S(NP(NP*       -    -   -   -       (ORG*       (ARG0*   (10
nw/wsj/12/wsj_1246   0    1               PLC   NNP              *)      -    -   -   -           *)           *     -
nw/wsj/12/wsj_1246   0    2                 ,     ,              *       -    -   -   -           *            *     -
nw/wsj/12/wsj_1246   0    3                 a    DT           (NP*       -    -   -   -           *            *     -
nw/wsj/12/wsj_1246   0    4             major    JJ              *       -    -   -   -           *            *     -
nw/wsj/12/wsj_1246   0    5           British    JJ              *       -    -   -   -       (NORP)           *     -
nw/wsj/12/wsj_1246   0    6    pharmaceutical    NN              *       -    -   -   -           *            *     -
nw/wsj/12/wsj_1246   0    7             maker    NN              *)   maker   -   1   -           *            *     -
nw/wsj/12/wsj_1246   0    8                 ,     ,              *)      -    -   -   -           *            *)   10)
nw/wsj/12/wsj_1246   0    9             sells   VBZ           (VP*     sell  01   1   -           *          (V*)    -
nw/wsj/12/wsj_1246   0   10               the    DT           (NP*       -    -   -   -           *       (ARG1*    (7
nw/wsj/12/wsj_1246   0   11              drug    NN              *)    drug   -   1   -           *            *)    7)
nw/wsj/12/wsj_1246   0   12             under    IN           (PP*       -    -   -   -           *   (ARGM-MNR*     -
nw/wsj/12/wsj_1246   0   13               the    DT        (NP(NP*       -    -   -   -           *            *    (2
nw/wsj/12/wsj_1246   0   14              name    NN              *)    name   -   1   -           *            *     -
nw/wsj/12/wsj_1246   0   15          Retrovir   NNP        (NP*))))      -    -   -   -    (PRODUCT)           *)    2)
nw/wsj/12/wsj_1246   0   16                 .     .             *))      -    -   -   -           *            *     -

nw/wsj/12/wsj_1246   0    0            A    DT    (TOP(S(NP*           -    -   -   -       *   (ARG0*   (ARG0*            *        -
nw/wsj/12/wsj_1246   0    1     Wellcome   NNP             *           -    -   -   -    (ORG)       *        *            *      (10)
nw/wsj/12/wsj_1246   0    2    spokesman    NN             *)          -    -   -   -       *        *)       *)           *        -
nw/wsj/12/wsj_1246   0    3     declined   VBD          (VP*      decline  02   2   -       *      (V*)       *            *        -
nw/wsj/12/wsj_1246   0    4           to    TO        (S(VP*           -    -   -   -       *   (ARG1*        *            *        -
nw/wsj/12/wsj_1246   0    5      comment    VB          (VP*      comment  01   1   -       *        *      (V*)           *        -
nw/wsj/12/wsj_1246   0    6           on    IN          (PP*           -    -   -   -       *        *   (ARG1*            *        -
nw/wsj/12/wsj_1246   0    7          the    DT       (NP(NP*           -    -   -   -       *        *        *            *       (6
nw/wsj/12/wsj_1246   0    8    discovery    NN             *)   discovery  01   1   -       *        *        *          (V*)       -
nw/wsj/12/wsj_1246   0    9           of    IN          (PP*           -    -   -   -       *        *        *       (ARG1*        -
nw/wsj/12/wsj_1246   0   10          the    DT          (NP*           -    -   -   -       *        *        *            *       (0
nw/wsj/12/wsj_1246   0   11     antibody    NN            *))          -    -   -   -       *        *        *            *)       0)
nw/wsj/12/wsj_1246   0   12           in    IN          (PP*           -    -   -   -       *        *        *   (ARGM-LOC*        -
nw/wsj/12/wsj_1246   0   13        Japan   NNP   (NP*))))))))          -    -   -   -    (GPE)       *)       *)           *)   (3)|6)
nw/wsj/12/wsj_1246   0   14            .     .            *))          -    -   -   -       *        *        *            *        -

nw/wsj/12/wsj_1246   0    0             But     CC         (TOP(S*           -    -   -   -           *    (ARGM-DIS*)     *             *             *     -
nw/wsj/12/wsj_1246   0    1          Andrew    NNP         (NP(NP*           -    -   -   -    (PERSON*        (ARG0*      *             *             *     -
nw/wsj/12/wsj_1246   0    2          Porter    NNP               *)          -    -   -   -           *)            *      *             *             *     -
nw/wsj/12/wsj_1246   0    3               ,      ,               *           -    -   -   -           *             *      *             *             *     -
nw/wsj/12/wsj_1246   0    4               a     DT         (NP(NP*           -    -   -   -           *             *      *             *             *     -
nw/wsj/12/wsj_1246   0    5            drug     NN           (NML*           -    -   -   -           *             *      *             *             *     -
nw/wsj/12/wsj_1246   0    6              -    HYPH               *           -    -   -   -           *             *      *             *             *     -
nw/wsj/12/wsj_1246   0    7        industry     NN               *)          -    -   -   -           *             *      *             *             *     -
nw/wsj/12/wsj_1246   0    8         analyst     NN               *)     analyst   -   1   -           *             *      *             *             *     -
nw/wsj/12/wsj_1246   0    9              at     IN            (PP*           -    -   -   -           *             *      *             *             *     -
nw/wsj/12/wsj_1246   0   10           Nikko    NNP         (NP(NP*           -    -   -   -       (ORG*             *      *             *             *     -
nw/wsj/12/wsj_1246   0   11      Securities   NNPS               *           -    -   -   -           *             *      *             *             *     -
nw/wsj/12/wsj_1246   0   12             Co.    NNP               *)          -    -   -   -           *)            *      *             *             *     -
nw/wsj/12/wsj_1246   0   13              in     IN            (PP*           -    -   -   -           *             *      *             *             *     -
nw/wsj/12/wsj_1246   0   14          London    NNP        (NP*)))))          -    -   -   -        (GPE)            *      *             *             *     -
nw/wsj/12/wsj_1246   0   15               ,      ,               *)          -    -   -   -           *             *)     *             *             *     -
nw/wsj/12/wsj_1246   0   16            said    VBD            (VP*          say  01   1   -           *           (V*)     *             *             *     -
nw/wsj/12/wsj_1246   0   17              if     IN   (SBAR(S(SBAR*           -    -   -   -           *        (ARG1*      *             *    (ARGM-ADV*     -
nw/wsj/12/wsj_1246   0   18             the     DT          (S(NP*           -    -   -   -           *             *      *        (ARG1*             *    (0
nw/wsj/12/wsj_1246   0   19         product     NN               *)     product   -   1   -           *             *      *             *)            *     0)
nw/wsj/12/wsj_1246   0   20            were    VBD            (VP*           be  03   1   -           *             *    (V*)            *             *     -
nw/wsj/12/wsj_1246   0   21              to     TO          (S(VP*           -    -   -   -           *             *      *             *             *     -
nw/wsj/12/wsj_1246   0   22              be     VB            (VP*           -    -   -   -           *             *      *             *             *     -
nw/wsj/12/wsj_1246   0   23    successfully     RB          (ADVP*)          -    -   -   -           *             *      *    (ARGM-MNR*)            *     -
nw/wsj/12/wsj_1246   0   24       developed    VBN      (VP*)))))))     develop  02   1   -           *             *      *           (V*)            *)    -
nw/wsj/12/wsj_1246   0   25              it    PRP            (NP*)          -    -   -   -           *             *      *             *        (ARG0*)   (0)
nw/wsj/12/wsj_1246   0   26           would     MD            (VP*           -    -   -   -           *             *      *             *    (ARGM-MOD*)    -
nw/wsj/12/wsj_1246   0   27       represent     VB            (VP*    represent  01   1   -           *             *      *             *           (V*)    -
nw/wsj/12/wsj_1246   0   28              ``     ``               *           -    -   -   -           *             *      *             *             *     -
nw/wsj/12/wsj_1246   0   29               a     DT         (NP(NP*           -    -   -   -           *             *      *             *        (ARG1*     -
nw/wsj/12/wsj_1246   0   30       potential     JJ               *           -    -   -   -           *             *      *             *             *     -
nw/wsj/12/wsj_1246   0   31          threat     NN               *)      threat   -   1   -           *             *      *             *             *     -
nw/wsj/12/wsj_1246   0   32              to     IN            (PP*           -    -   -   -           *             *      *             *             *     -
nw/wsj/12/wsj_1246   0   33             the     DT         (NP(NP*           -    -   -   -           *             *      *             *             *     -
nw/wsj/12/wsj_1246   0   34            long     JJ           (NML*           -    -   -   -           *             *      *             *             *     -
nw/wsj/12/wsj_1246   0   35              -    HYPH               *           -    -   -   -           *             *      *             *             *     -
nw/wsj/12/wsj_1246   0   36            term     NN               *)          -    -   -   -           *             *      *             *             *     -
nw/wsj/12/wsj_1246   0   37       viability     NN               *)          -    -   -   -           *             *      *             *             *     -
nw/wsj/12/wsj_1246   0   38              of     IN            (PP*           -    -   -   -           *             *      *             *             *     -
nw/wsj/12/wsj_1246   0   39        Retrovir    NNP   (NP*))))))))))          -    -   -   -    (PRODUCT)            *)     *             *             *)   (2)
nw/wsj/12/wsj_1246   0   40               .      .              *))          -    -   -   -           *             *      *             *             *     -

#end document
